# Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive Disorder

> **NCT01997580** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Bundang Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** escitalopram

## Key facts

- **NCT ID:** NCT01997580
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-07
- **Primary completion:** 2016-12
- **Final completion:** 2018-12
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2013-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01997580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01997580, "Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01997580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*